GBM tissue samples were subjected to immunohistochemistry for CD68 (Figure 1A) and CD163 (Figure 2A) in order to evaluate total and M2 macrophages, respectively, in both the center side of the tumor and in the healthy surrounding areas. This evidence concerns the gene CD163 and glioblastoma.